3-Piperidinecarboxylic acid, 1-ethyl-2-(4-methoxyphenyl)-6-oxo-, (2R,3R)-rel- - Names and Identifiers
3-Piperidinecarboxylic acid, 1-ethyl-2-(4-methoxyphenyl)-6-oxo-, (2R,3R)-rel- - Physico-chemical Properties
Molecular Formula | C15H19NO4
|
Molar Mass | 277.32 |
Storage Condition | Room Temprature |
Sensitive | Irritant |
MDL | MFCD08687761 |
3-Piperidinecarboxylic acid, 1-ethyl-2-(4-methoxyphenyl)-6-oxo-, (2R,3R)-rel- - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Hazard Class | IRRITANT |
3-Piperidinecarboxylic acid, 1-ethyl-2-(4-methoxyphenyl)-6-oxo-, (2R,3R)-rel- - Introduction
(2R,3R)-1-Ethyl-2-(4-methoxy-phenyl)-acid is an organic compound containing a heterocyclic structure and substituents in its chemical structure.
Nature:
-Appearance: Usually a white crystalline solid
-Molecular formula: C16H21NO4
-Molecular weight: 291.34g/mol
-melting point: about 150-152 ℃
-Solubility: Soluble in some organic solvents, such as chloroform and ethanol
Use:
The main use of this compound is as a raw material or intermediate in organic synthesis. It can be used in the pharmaceutical industry to synthesize specific classes of drugs, such as anti-cancer drugs, etc.
Preparation Method:
The method of preparing (2, 3R)-1-Ethyl-2-(4-methoxy-phenyl)-Cr acid can be obtained by appropriate organic synthetic chemistry reactions, usually starting materials and reaction conditions. The specific synthetic route may vary depending on the purpose and requirements of the research, and organic synthesis experiments can be carried out in the laboratory.
Safety Information:
Less information is available on the safety of (2, 3R)-1-Ethyl-2-(4-methoxy-phenyl)-5-acid. However, as chemical substances, laboratory practices should be followed when handling is required. Use should wear appropriate protective equipment to avoid contact with eyes, skin and respiratory tract. In addition, the fixture is required to be stored properly and away from the fire and oxidant. If any discomfort or accident occurs, seek medical help immediately.
Last Update:2024-04-09 21:54:55